Status:
COMPLETED
The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Hemoglobinuria, Paroxysmal
Eligibility:
All Genders
7+ years
Brief Summary
This study is designed to better understand the molecular biology of paroxysmal nocturnal hemoglobinuria (PNH) and to determine if prion protein (PrP) functions in long term hematopoietic stem cell re...
Detailed Description
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by hemolytic anemia, thrombosis, and variable cytopenia. It can be associated with significant morbidity including acute kidney failure, cere...
Eligibility Criteria
Inclusion
- Subjects suspected of or diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Age \> 7
Exclusion
- 1\. Those not meeting the inclusion criteria
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00721864
Start Date
May 1 2006
End Date
December 1 2010
Last Update
August 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Utah
Salt Lake City, Utah, United States, 84132